Literature DB >> 17005737

Use of the BACTEC Mycobacteria Growth Indicator Tube 960 automated system for recovery of Mycobacteria from 9,558 extrapulmonary specimens, including urine samples.

Doris Hillemann1, Elvira Richter, Sabine Rüsch-Gerdes.   

Abstract

The BACTEC Mycobacteria Growth Indicator Tube 960 (MGIT 960) system was applied for recovery of mycobacteria from extrapulmonary specimens and compared with solid media (Löwenstein-Jensen and Stonebrink). A total of 9,558 specimens were investigated, comprising 3,074 body fluids, 1,878 tissues, and 2,069 urine samples, from which the recovery of mycobacteria was not yet established for MGIT 960. In total, the MGIT 960 was able to detect 446 (90.3%) of the 494 isolates of Mycobacterium tuberculosis complex (MTBC) and 223 (86.0%) out of the 259 isolates of nontuberculous mycobacteria (NTM). In comparison to this, culture on solid medium revealed 358 (72.6%) MTBC isolates and 164 (66.8%) NTM isolates. While 136 (27.6%) of the MTBC isolates and 95 (19.2%) of the NTM isolates were recovered from the MGIT 960 only, 48 (9.7%) of the MTBC isolates and 36 (13.9%) NTM isolates grew only on solid media. Thus, the overall sensitivities for the recovery of mycobacteria from extrapulmonary specimens with MGIT 960 and solid media were 88.8% and 69.3%, respectively. However, the efficiency of the MGIT 960 system can be maximized with additional culture on solid media.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17005737      PMCID: PMC1698359          DOI: 10.1128/JCM.00829-06

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  17 in total

1.  Evaluation of the BACTEC MGIT 960 and the MB/BacT systems for recovery of mycobacteria from clinical specimens and for species identification by DNA AccuProbe.

Authors:  F Alcaide; M A Benítez; J M Escribà; R Martín
Journal:  J Clin Microbiol       Date:  2000-01       Impact factor: 5.948

2.  Comparison of the automated nonradiometric Bactec MGIT 960 system with Löwenstein-Jensen, Coletsos, and Middlebrook 7H11 solid media for recovery of mycobacteria.

Authors:  P Idigoras; X Beristain; A Iturzaeta; D Vicente; E Pérez-Trallero
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2000-05       Impact factor: 3.267

3.  Evaluation of the BACTEC MGIT 960 and MB BAC/T systems for routine detection of Mycobacterium tuberculosis.

Authors:  T Whyte; B Hanahoe; T Collins; G Corbett-Feeney; M Cormican
Journal:  J Clin Microbiol       Date:  2000-08       Impact factor: 5.948

4.  Comparison of the Automated Mycobacteria Growth Indicator Tube System (BACTEC 960/MGIT) with Löwenstein-Jensen medium for recovery of mycobacteria from clinical specimens.

Authors:  Dongsi Lu; Bobbi Heeren; W Michael Dunne
Journal:  Am J Clin Pathol       Date:  2002-10       Impact factor: 2.493

5.  Meta-analysis of BACTEC MGIT 960 and BACTEC 460 TB, with or without solid media, for detection of mycobacteria.

Authors:  M Cruciani; C Scarparo; M Malena; O Bosco; G Serpelloni; C Mengoli
Journal:  J Clin Microbiol       Date:  2004-05       Impact factor: 5.948

6.  Rapid identification of mycobacteria to the species level by polymerase chain reaction and restriction enzyme analysis.

Authors:  A Telenti; F Marchesi; M Balz; F Bally; E C Böttger; T Bodmer
Journal:  J Clin Microbiol       Date:  1993-02       Impact factor: 5.948

7.  Extrapulmonary tuberculosis active infection misdiagnosed as cancer: Mycobacterium tuberculosis disease in patients at a Comprehensive Cancer Center (2001-2005).

Authors:  Gabriel M Aisenberg; Kalen Jacobson; Roy F Chemaly; Kenneth V Rolston; Isaam I Raad; Amar Safdar
Journal:  Cancer       Date:  2005-12-15       Impact factor: 6.860

8.  Evaluation of genotype MTBC assay for differentiation of clinical Mycobacterium tuberculosis complex isolates.

Authors:  Elvira Richter; Michael Weizenegger; Sabine Rüsch-Gerdes; Stefan Niemann
Journal:  J Clin Microbiol       Date:  2003-06       Impact factor: 5.948

9.  Comparative evaluation of the BACTEC MGIT 960 system with solid medium for isolation of mycobacteria.

Authors:  J J Lee; J Suo; C B Lin; J D Wang; T Y Lin; Y C Tsai
Journal:  Int J Tuberc Lung Dis       Date:  2003-06       Impact factor: 2.373

Review 10.  Mycobacterial infections of the head and neck.

Authors:  Karsten Munck; Aditi H Mandpe
Journal:  Otolaryngol Clin North Am       Date:  2003-08       Impact factor: 3.346

View more
  24 in total

1.  [Genitourinary tuberculosis in Germany: diagnosis and treatment].

Authors:  S Lenk
Journal:  Urologe A       Date:  2011-12       Impact factor: 0.639

2.  Occurrence of rpoB mutations in isoniazid-resistant but rifampin-susceptible Mycobacterium tuberculosis isolates from Germany.

Authors:  Sönke Andres; Doris Hillemann; Sabine Rüsch-Gerdes; Elvira Richter
Journal:  Antimicrob Agents Chemother       Date:  2013-10-21       Impact factor: 5.191

3.  True facets of TB diagnosis in 2012: Hypes and realities.

Authors:  S K Parida
Journal:  Eur J Microbiol Immunol (Bp)       Date:  2012-12-11

4.  A Novel Solid Medium for Culturing Mycobacterium tuberculosis Isolates from Clinical Specimens.

Authors:  S Asmar; S Chatellier; C Mirande; A van Belkum; I Canard; D Raoult; M Drancourt
Journal:  J Clin Microbiol       Date:  2015-06-03       Impact factor: 5.948

5.  Unreliable detection of Mycobacterium xenopi by the nonradiometric Bactec MGIT 960 culture system.

Authors:  Claudio Piersimoni; Domenico Nista; Stefano Bornigia; Giancarlo Gherardi
Journal:  J Clin Microbiol       Date:  2009-01-14       Impact factor: 5.948

6.  Rapid mycobacterial liquid culture-screening method for Mycobacterium avium complex based on secreted antigen-capture enzyme-linked immunosorbent assay.

Authors:  Sung Jae Shin; Kelly Anklam; Elizabeth J B Manning; Michael T Collins
Journal:  Clin Vaccine Immunol       Date:  2009-03-04

7.  Rapid and reliable method for quantification of Mycobacterium paratuberculosis by use of the BACTEC MGIT 960 system.

Authors:  Sung Jae Shin; Jun Hee Han; Elizabeth J B Manning; Michael T Collins
Journal:  J Clin Microbiol       Date:  2007-04-11       Impact factor: 5.948

8.  Treatment of nontuberculous mycobacterial pulmonary disease: an official ATS/ERS/ESCMID/IDSA clinical practice guideline.

Authors:  Charles L Daley; Jonathan M Iaccarino; Christoph Lange; Emmanuelle Cambau; Richard J Wallace; Claire Andrejak; Erik C Böttger; Jan Brozek; David E Griffith; Lorenzo Guglielmetti; Gwen A Huitt; Shandra L Knight; Philip Leitman; Theodore K Marras; Kenneth N Olivier; Miguel Santin; Jason E Stout; Enrico Tortoli; Jakko van Ingen; Dirk Wagner; Kevin L Winthrop
Journal:  Eur Respir J       Date:  2020-07-07       Impact factor: 16.671

9.  Treatment of Nontuberculous Mycobacterial Pulmonary Disease: An Official ATS/ERS/ESCMID/IDSA Clinical Practice Guideline.

Authors:  Charles L Daley; Jonathan M Iaccarino; Christoph Lange; Emmanuelle Cambau; Richard J Wallace; Claire Andrejak; Erik C Böttger; Jan Brozek; David E Griffith; Lorenzo Guglielmetti; Gwen A Huitt; Shandra L Knight; Philip Leitman; Theodore K Marras; Kenneth N Olivier; Miguel Santin; Jason E Stout; Enrico Tortoli; Jakko van Ingen; Dirk Wagner; Kevin L Winthrop
Journal:  Clin Infect Dis       Date:  2020-08-14       Impact factor: 9.079

10.  An integrated approach to rapid diagnosis of tuberculosis and multidrug resistance using liquid culture and molecular methods in Russia.

Authors:  Yanina Balabanova; Francis Drobniewski; Vladyslav Nikolayevskyy; Annika Kruuner; Nadezhda Malomanova; Tatyana Simak; Nailya Ilyina; Svetlana Zakharova; Natalya Lebedeva; Heather L Alexander; Rick O'Brien; Hojoon Sohn; Anastasia Shakhmistova; Ivan Fedorin
Journal:  PLoS One       Date:  2009-09-23       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.